The fact that curcumin is a suppressor of miR-155 in tumor cells and a restorer of IL2RG in blood cells [21] holds the potential to be an effective preventive therapy against cancer formation in BRCA1-metylation carriers. The gene discussed is BRCA1; the disease is neoplasm.